MabCampath (Alemtuzumab) is used for the treatment of patients with Chronic Lymphocytic Leukemia, Multiple Sclerosis, Kidney Transplantation

Campath is indicated for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been treated with alkylating agents and who have failed fludarabine therapy. Determination of the effectiveness of Campath is based on overall response rates. (See CLINICAL STUDIES.) Comparative, randomized trials demonstrating increased survival or clinical benefits such as improvement in disease-related symptoms have not yet been conducted.

MabCampath (Alemtuzumab) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of MabCampath (Alemtuzumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the MabCampath (Alemtuzumab) medicine cost price in India.

The order for MabCampath (Alemtuzumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Alemtuzumab is used to treat a certain type of leukemia (B-cell chronic lymphocytic leukemia, also known as B-CLL). This medication works by stopping the growth of cancer cells. Alemtuzumab is also used to treat multiple sclerosis

MabCampath (Alemtuzumab) , for intravenous use Initial U.S. Approval: 2017

Generic Name: Alemtuzumab

Available only from a restricted distribution program injectable solution 10mg/mL (Lemtrada; 1.2mL/vial [12mg/1.2mL]) 30mg/mL (Campath; 1mL/vial)

Mabcampath (Alemtuzumab)

MabCampath (Alemtuzumab) is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

MabCampath (Alemtuzumab) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand MabCampath (Alemtuzumab) on prescription and Import License in Patient's Name only.

For overseas patients, MabCampath (Alemtuzumab) can be made available in Send your enquiry to find MabCampath (Alemtuzumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for MabCampath (Alemtuzumab) .

For MabCampath (Alemtuzumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Alemtuzumab Increases CMV Infection Risk For More Details

Alemtuzumab Benefits Persist in Multiple Sclerosis For More Details

Get Access To FDA Approved Drug MabCampath injection In india

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in a form of leukaemia known as B cell chronic lymphocytic leukaemia (B-CLL) treatment. Brand Name "MabCampath injection" or Generic Name "Alemtuzumab injection" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.